Biomarkers are biological molecules found in blood, other body fluids or tissues, that are signs of a normal or abnormal process, a disease or a condition. Biomarkers may be used to observe how well the body responds to treatment for a disease or condition.
BioM-Pathfinder is a fully-automated cartridge-based system that measures select biomarkers from ocular fluid. For example, when tears are tested, the simple procedure involves:
Grow Laboratories, along with the Narayana Nethralaya group of eye hospitals, after extensive research, has found that 8 biomarkers are critical and adequate for the analysis of ocular samples like tears, aqueous humor and vitreous humor. With a clinically validated database, the artificial intelligence (AI) based report generates an analysis of 4 biomarkers in a single cartridge. To have all 8 biomarkers analysed, the extended report needs 2 cartridges. The report provides actionable information before any type of treatment or intervention is done.
One cartridge can hold 32 samples. If the test is done on both the eyes of a patient, it can accommodate samples from 16 patients.
No. The cartridge comes with microfluidic technology and is for one-time use only.
Yes, multiple sample types like tears, aqueous humor or vitreous humor can be analysed in a single test.
A single cartridge takes around 90 minutes to be tested.
Yes. The samples can be stored at a temperature of 4oC up to 72 hours.
Yes, the machine will be supplied with the complete kit/accessories required to conduct the tests. Please write an e-mail to contactus@novomoldx.com for further details
The cost depends on the number of samples in the cartridge. To know more, please write an e-mail to contactus@novomoldx.com
Many clinical research papers have been published worldwide on the importance of biomarkers in the accurate diagnosis of eye disease.
View Clinical Papers
Narayana Nethralaya, one of the most trusted eye hospitals in India, has developed multiple research wings, including Narayana Netralaya Foundation. Narayana Netralaya Foundation has recently spun off a startup named Novomol-Dx with the aim of bringing cutting edge molecular research to the clinics worldwide.